Kahala Biosciences Inc.

Kahala Biosciences Inc is a US-based provider of comprehensive COVID-19 testing solutions, offering peace of mind through its KahalaCare subscription service. We specialize in affordable, frequent testing, adhering to CDC guidelines and supporting individuals and families in safely reclaiming their lives. KahalaCare provides an end-to-end testing plan, simplifying the process and reducing the burden of testing.

Our focus is on delivering accessible and reliable COVID-19 testing, addressing a critical need during the ongoing pandemic. We leverage our expertise in medical device development and commercialization, supported by Koa Accel, to rapidly deploy innovative solutions.

Kahala Biosciences is committed to public health and safety, providing a vital service to communities across the United States. We are a portfolio company of Koa Accel, a hyper-accelerator dedicated to transforming medical device ideas into thriving commercial ventures.